Difference Between Generic ANDA and 505(b)(2) Submissions

Byipharmacist

In the pharmaceutical industry, both generic (ANDA) and 505(b)(2) submissions are key regulatory pathways, but they serve different purposes.

Generic (ANDA): This is for drugs that are bioequivalent to an already approved product. ANDA submissions must show the drug is the same in dosage, form, strength, and administration route as the reference drug. No new clinical data are required.

505(b)(2): This is a hybrid pathway allowing approval of drugs that are similar but not identical to an existing product. Unlike ANDA, it can include new indications, formulations, or delivery methods and may require new clinical data to support these changes.

Both pathways offer unique routes to market with varying levels of innovation and regulatory complexity. The table below provides a simple comparison of both pathways with some examples.


Read also:


Resource Person: Bhupesh Pratap

Similar Posts

  • Difference Between RABS and Isolator

    Byipharmacist

    RABS (Restricted Access Barrier System) and isolators are both important containment systems used in pharmaceutical manufacturing to protect products from contamination and ensure operator safety. Let’s take a closer look at their specifications, applications, and qualification tests.   Specifications – RABS: RABS is a semi-closed system that creates a physical barrier between the operator and…

  • |

    Difference Between CSV and CSA

    Byipharmacist

    Introduction In September 2022, the U.S. Food and Drug Administration (FDA) released a draft guidance on software validation, introducing a new approach called Computer Software Assurance (CSA) for production and quality system software. This guidance marks a shift from the traditional method of software validation, known as computer system validation (CSV), towards a risk-based approach….

  • Difference Between HPLC and UHPLC

    Byipharmacist

    HPLC (High-Performance Liquid Chromatography) and UHPLC (Ultra-High Performance Liquid Chromatography) are both powerful techniques used in chemical analysis, but there are some key differences between them: Pressure and Particle Size: Speed and Efficiency: Applications: Cost and Maintenance: Personal Experience with Waters and Agilent Systems I’ve worked with three systems so far: Waters, Agilent 1290, and…

  • |

    Difference Between QC and QA

    Byipharmacist

    The main similarities and differences between Quality Control (QC) and Quality Assurance (QA) are as follows: Similarities 1. Both quality control and  quality assurance are essential components of the pharmaceutical industry. 2. Both aim to ensure that pharmaceutical products meet the required standards and regulations. 3. Both involve monitoring and evaluating processes to identify any…

  • GLP vs GMP vs GCP | Similarities and Differences

    Byipharmacist

    Good Manufacturing Processes (GMPs) for Quality Assurance  GMPs are the backbone of consistent and controlled production of products, meeting the required quality standards for their intended use. They cover both production and quality control, ensuring excellence in the manufacturing process.    Good Clinical Practice (GCP) for Ethical Trials GCP sets the gold standard for designing,…

  • | |

    Difference Between GMP and GLP

    Byipharmacist

    GMP (Good Manufacturing Practice) and GLP (Good Laboratory Practice) are both quality assurance systems that are crucial in the pharmaceutical manufacturing industry. While they share some similarities, there are also notable differences between the two concepts.   Standards: 1. GMP: GMP focuses on ensuring that pharmaceutical products are consistently produced and controlled according to quality…

Leave a Reply